Atlas Trials

A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

Clinical trial NCT01439568 · COMPLETED

Trial details

NCT number
NCT01439568
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extensive Stage Small Cell Lung Carcinoma
Start date
2011-09-01
Primary completion
2014-01-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.